An example of deceptive headlines for Adstiladrin
https://www.medpagetoday.com/meetingcoverage/suo/107650
The headline is
First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Response
— A quarter patients with high-risk, BCG-unresponsive disease were recurrence free at 3 years
Whereas what it should read is a quarter of those who responded AT ALL were recurrence free at 3 years.
Or it could read
12% of those initialy treated were recurrence free at 3 years.